Schizophrenia
Showing NaN - NaN of 145
Schizophrenia Trial in New York (Overnight polysomnography examinations)
Recruiting
- Schizophrenia
- Overnight polysomnography examinations
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Apr 4, 2022
Schizophrenia, Schizoaffective Disorder Trial in United States (Clozapine, treatment as usual)
Recruiting
- Schizophrenia
- Schizoaffective Disorder
- Clozapine
- treatment as usual
-
Los Angeles, California
- +6 more
Mar 25, 2022
Long Acting Injectable Medications in Schizophrenia
Active, not recruiting
- Schizophrenia
-
Tucson, Arizona
- +56 more
Feb 10, 2022
Dysmyelination in Cognitive Impairment of Psychotic Spectrum
Recruiting
- Schizophrenia
- Bipolar Disorder
- Cognitive Function Assessments
-
New York, New YorkNew York University School of Medicine
Feb 10, 2022
Psychosis, Schizophrenia, Schizoaffective Disorder Trial in New York (ceftriaxone, Normal Saline)
Terminated
- Psychosis
- +2 more
- ceftriaxone
- Normal Saline
-
New York, New YorkNYS Psychiatric Institute
Dec 14, 2021
Psychosis, Schizoaffective Disorder, Schizophrenia Trial in New York (OnTrack>TheGame (OTG), Recovery Videos (RV))
Completed
- Psychosis
- +2 more
- OnTrack>TheGame (OTG)
- Recovery Videos (RV)
-
New York, New YorkNew York State Psychiatric Institute
Nov 24, 2021
Schizophrenia Trial in New York (ITI-007)
Terminated
- Schizophrenia
-
New York, New YorkNew York State Psychiatric Institute
Nov 2, 2021
Schizophrenia, Alcohol Use Disorder Trial in Bulgaria, Poland, United States (Samidorphan + olanzapine (ALKS 3831), Placebo +
Completed
- Schizophrenia
- Alcohol Use Disorder
- Samidorphan + olanzapine (ALKS 3831)
- Placebo + olanzapine
-
Little Rock, Arkansas
- +70 more
Sep 14, 2021
Schizophrenia, Schizoaffective Disorder Trial in New York (Active Transcranial direct current stimulation (tDCS), Sham
Completed
- Schizophrenia
- Schizoaffective Disorder
- Active Transcranial direct current stimulation (tDCS)
- +3 more
-
New York, New YorkNew York State Psychiatric Institute
Jun 16, 2021
Schizophrenia, Schizoaffective Disorder, Overweight Trial in United States (Lorcaserin, Metformin, Placebo)
Potential Biomarkers in Schizophrenia and Healthy Volunteer
Completed
- Schizophrenia
- Event-Related Potentials (ERP) and Electroencephalogram (EEG) testing with the COGNISION® System
-
Garden Grove, California
- +3 more
Feb 22, 2021
Schizophrenia Trial in New York (Cognitive remediation therapy)
Completed
- Schizophrenia
- Cognitive remediation therapy
-
New York, New YorkManhattan Psychiatric Center
Oct 2, 2020
Schizophrenia, Schizoaffective Disorder Trial in Bronx, Brooklyn, New York (Cognitive remediation)
Completed
- Schizophrenia
- Schizoaffective Disorder
- Cognitive remediation
-
Bronx, New York
- +4 more
Sep 11, 2020
Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia
Withdrawn
- Schizophrenia
- NPA radiotracer
- +2 more
-
New York, New YorkNYU Langone Health
May 27, 2020